DermTech Adds Dr. Harold Rabinovitz to Scientific Advisory Board

Wednesday, November 08, 2017 | Personnel/Company News , Skin Cancer

DermTech, Inc., appointed Harold Rabinovitz, MD to its Scientific Advisory Board. Dr. Rabinovitz is a Board Certified Dermatologist and a voluntary Clinical Professor of Dermatology at University of Miami School of Medicine. He is world-renown for his work in dermoscopy and confocal microscopy.

Dr. Rabinovitz's research interests focus on identification of tumor characteristics with new research instruments and education on early tumor detection.

"Melanoma is the great masquerader and millions of moles have at least one feature that falls into the criteria dermatologists refer to as the ABCDEs of melanoma," said Dr. Rabinovitz. "That's why in addition to visually inspecting the skin, high-tech diagnostic tools can be helpful in determining whether a suspicious mole is actually a melanoma or a benign lesion."

Dr. Rabinovitz graduated Cum Laude from Princeton University and received his medical degree from University of Miami School of Medicine. He performed his internship at Mt. Sinai Medical Center and completed his dermatology residency at New York University Medical Center.

DermTech markets and develops products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. DermTech analyzes skin biopsy samples collected non-invasively using an adhesive patch rather than a scalpel.

Next Story


You must be logged in to leave a comment.